精子等离子体金属混合物和精子精子症之间的剂量反应关系:一项基于医院的病例控制研究
Xiangxiang Liu1, Chen Chen1, Yiting Chen1
1Department of Clinical Laboratory, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, Jiangsu 210004, China.
概括
,和等精液等离子体微量元素的升高与男性不孕症 (oligo-astheno-teratozoospermia) 有关. 这项研究揭示了这些因素与OAT风险之间的复杂相互作用.
科学领域:
- 生殖生物学 生殖生物学
- 环境毒理学环境毒理学
- 人类健康 人类健康 人类健康
背景情况:
- 奥利戈-阿斯泰诺-特拉托动物精子症 (OAT) 影响30%的男性,影响生育能力.
- 之前的研究集中在单个微量元素上,对组合效应留下了知识差距.
- 了解多元因素的影响对于OAT病原发生至关重要.
研究的目的:
- 调查精液等离子体微量元素与OAT之间的关联.
- 探索OAT中多个元素的联合作用和剂量反应关系.
主要方法:
- 在743个OAT病例和179个使用ICP-MS的对照中量化了精液等离子元素.
- 用于剂量反应建模的受限立方线.
- 用BKMR和WQS回归进行联合效应分析.
主要成果:
- 在OAT患者的精液血Ca,Li,Mn,Co,Zn和Cd的升高.
- 对Li的非线性剂量反应,对Ca,Mn,Co,Zn,Cd的线性.
- 在混合物模型中,Cd,Li和Mn被确定为OAT风险的主要驱动因素.
结论:
- 精液等离子体微量元素dyshomeostasis与OAT风险有关.
- ,和发挥着重要的作用.
- 微量元素和OAT之间的关系的基础是复杂的机制.
相关概念视频
Dose-Response Relationship: Overview
5.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.2K
Dose-Response Relationship: Potency and Efficacy
6.7K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.7K
Dose-Response Relationship: Selectivity and Specificity
9.9K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
9.9K
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
24
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
24
Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship
21
Pharmacodynamics explores the relationship between drug concentration and its effect. In a quantal response drug, the duration of action better correlates with drug concentration, while for graded effect drugs, the intensity of response is more relevant. This intensity depends on the dose, drug removal rate, and the region of the concentration–response curve.The concentration–response curve can be divided into three regions. Region 3 (80–100% maximum response) demonstrates...
21
Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
18
A drug’s dosage and pharmacokinetic properties determine how quickly it acts, how intense its effects are, and how long it lasts. Higher doses increase drug concentration at receptor sites, producing a hyperbolic curve when pharmacologic response is plotted against drug dose. Converting this scale to a log-linear format results in a sigmoidal curve, better representing dose–response relationships.For drugs following a one-compartment model, the pharmacologic response is directly...
18


